Cooperativity basis for small-molecule stabilization of protein-protein interactions

被引:32
|
作者
de Vink, Pim J. [1 ,2 ]
Andrei, Sebastian A. [1 ,2 ]
Higuchi, Yusuke [3 ]
Ottmann, Christian [1 ,2 ,4 ]
Milroy, Lech-Gustav [1 ,2 ]
Brunsveld, Luc [1 ,2 ]
机构
[1] Eindhoven Univ Technol, Lab Chem Biol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands
[2] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands
[3] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Japan
[4] Univ Duisburg Essen, Dept Organ Chem, Duisburg, Germany
关键词
ALLOSTERIC LIGANDS; STRUCTURAL BASIS; BINDING; DEGRADATION; DOMAIN;
D O I
10.1039/c8sc05242e
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A cooperativity framework to describe and interpret small-molecule stabilization of protein-protein interactions (PPI) is presented. The stabilization of PPIs is a versatile and emerging therapeutic strategy to target specific combinations of protein partners within the protein interactome. Currently, the potency of PPI stabilizers is typically expressed by their apparent affinity or EC50. Here, we propose that the effect of a PPI stabilizer be best described involving the cooperativity factor, alpha, between the stabilizer and binding partners in addition to the intrinsic affinity, K-D(II), of the stabilizer for one of the apo-proteins. By way of illustration, we combine fluorescence polarization measurements with thermodynamic modeling to determine the a and K-D(II) for the PPI stabilization of 14-3-3 and TASK3 by fusicoccin-A (FC-A) and validate our approach by studying other PPI-partners of 14-3-3 proteins. Finally, we characterize a library of different stabilizer compounds, and perform structure-activity relationship studies in which molecular changes could be attributed to either changes in cooperativity or intrinsic affinity. Such insights should aid in the development of more effective protein-protein stabilizer drugs.
引用
收藏
页码:2869 / 2874
页数:6
相关论文
共 50 条
  • [11] Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
    Arkin, Michelle R.
    Tang, Yinyan
    Wells, James A.
    CHEMISTRY & BIOLOGY, 2014, 21 (09): : 1102 - 1114
  • [12] A systematic method for identifying small-molecule modulators of protein-protein interactions
    Horswill, AR
    Savinov, SN
    Benkovic, SJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15591 - 15596
  • [13] TNF Superfamily Protein-Protein Interactions: Feasibility of Small-Molecule Modulation
    Song, Yun
    Buchwald, Peter
    CURRENT DRUG TARGETS, 2015, 16 (04) : 393 - 408
  • [14] Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
    Arkin, MR
    Wells, JA
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) : 301 - 317
  • [15] Small-molecule modulation of p53 protein-protein interactions
    Kuusk, Ave
    Boyd, Helen
    Chen, Hongming
    Ottmann, Christian
    BIOLOGICAL CHEMISTRY, 2020, 401 (08) : 921 - 931
  • [16] Turning Peptide Ligands into Small-Molecule Inhibitors of Protein-Protein Interactions
    Hashimoto, Chie
    Eichler, Jutta
    CHEMBIOCHEM, 2015, 16 (13) : 1855 - 1856
  • [17] Small-molecule binding sites to explore protein-protein interactions in the cancer proteome
    Xu, David
    Jalal, Shadia I.
    Sledge, George W., Jr.
    Meroueh, Samy O.
    MOLECULAR BIOSYSTEMS, 2016, 12 (10) : 3067 - 3087
  • [18] Small-molecule modulators of 14-3-3 protein-protein interactions
    Ottmann, Christian
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4058 - 4062
  • [19] Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists
    Xu, David
    Bum-Erdene, Khuchtumur
    Si, Yubing
    Zhou, Donghui
    Ghozayel, Mona K.
    Meroueh, Samy O.
    CHEMMEDCHEM, 2017, 12 (21) : 1794 - 1809
  • [20] Covalent modification as a strategy to block protein-protein interactions with small-molecule drugs
    Way, JC
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (01) : 40 - 46